Latest news with #AngelaBrown
Yahoo
2 days ago
- Business
- Yahoo
The Cannabist Company Introduces COAST Cannabis Co. Edibles to Maryland Market
CHELMSFORD, Mass., June 10, 2025--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) ("The Cannabist Company" or the "Company"), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the launch of COAST Cannabis Co. edibles in Maryland, bringing a new selection of premium, function-forward gummies to adult-use consumers and medical patients alike. This launch marks the first step in the partnership between The Cannabist Company and COAST Cannabis Co. ("COAST"), a woman-owned & led cannabis edibles company. Made with organic ingredients and free from artificial additives or unnecessary sugar coatings, COAST's gummies deliver a consistent, enjoyable experience. The launch showcases COAST's award-winning ratio gummies, expertly formulated to offer a variety of effects with varying cannabinoid ratios and a range of fruit-forward flavors. From the energizing Raspberry Lime enhanced with THCv to the restorative Sleep Suite powered by CBN and bursting with bold flavors like Blueberry, Cranberry Pomegranate, and Grape, each gummy reflects COAST's unwavering commitment to purpose and wellness. "COAST Cannabis Co. is known for crafting top-notch, innovative products, and we couldn't be more excited to bring their gummies to Maryland," said Catie Dunn, Director, Commercial Partnerships, The Cannabist Company. "Partnering with amazing brands like COAST empowers us to keep raising the bar, giving consumers more delicious, high-quality cannabis options in the most in-demand categories. Their gummies complement our existing portfolio by offering a variety of formulations and effects to meet different consumer needs. This launch is all about flavor, fun and expanding access to the best in the business." "We're beyond excited to bring COAST to Maryland and introduce our gummies to a whole new community of cannabis lovers," said Angela Brown, Co-Founder and CEO of COAST Cannabis Co. "At COAST, we're all about creating high-quality, clean, and delicious edibles that people can feel good about. Partnering with The Cannabist Company allows us to expand our mission while staying true to our roots—delivering products made with care, integrity, and a little taste of the coast in every bite." The infused gummies are now available at all gLeaf and Columbia Care locations in Maryland. In the coming months, COAST artisan chocolates will also be available. Find your local Maryland dispensary here: About The Cannabist Company (f/k/a Columbia Care) The Cannabist Company, formerly known as Columbia Care, is one of the most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 12 U.S. jurisdictions. The Company operates 81 facilities including 64 dispensaries and 17 cultivation and manufacturing facilities, including those under development. Columbia Care, now The Cannabist Company, is one of the original multi-state providers of cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the Company launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit Caution Concerning Forward-Looking Statements This press release contains certain statements that constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable securities laws and reflect the Company's current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company's ability to execute on retail, wholesale, brand and product initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. In addition, security holders should review the risk factors discussed under "Risk Factors" in Columbia Care's Form 10-K for the year ended December 31, 2023, as filed with Canadian and U.S. securities regulatory authorities and described from time to time in subsequent documents filed with applicable securities regulatory authorities. View source version on Contacts Investors & MediaLee Ann EvansSVP, Capital Marketsinvestor@ Mediamedia@ Sign in to access your portfolio
Business Wire
2 days ago
- Business
- Business Wire
The Cannabist Company Introduces COAST Cannabis Co. Edibles to Maryland Market
CHELMSFORD, Mass.--(BUSINESS WIRE)-- The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) ('The Cannabist Company' or the 'Company'), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the launch of COAST Cannabis Co. edibles in Maryland, bringing a new selection of premium, function-forward gummies to adult-use consumers and medical patients alike. This launch marks the first step in the partnership between The Cannabist Company and COAST Cannabis Co. ('COAST'), a woman-owned & led cannabis edibles company. Made with organic ingredients and free from artificial additives or unnecessary sugar coatings, COAST's gummies deliver a consistent, enjoyable experience. The launch showcases COAST's award-winning ratio gummies, expertly formulated to offer a variety of effects with varying cannabinoid ratios and a range of fruit-forward flavors. From the energizing Raspberry Lime enhanced with THCv to the restorative Sleep Suite powered by CBN and bursting with bold flavors like Blueberry, Cranberry Pomegranate, and Grape, each gummy reflects COAST's unwavering commitment to purpose and wellness. "COAST Cannabis Co. is known for crafting top-notch, innovative products, and we couldn't be more excited to bring their gummies to Maryland," said Catie Dunn, Director, Commercial Partnerships, The Cannabist Company. 'Partnering with amazing brands like COAST empowers us to keep raising the bar, giving consumers more delicious, high-quality cannabis options in the most in-demand categories. Their gummies complement our existing portfolio by offering a variety of formulations and effects to meet different consumer needs. This launch is all about flavor, fun and expanding access to the best in the business.' 'We're beyond excited to bring COAST to Maryland and introduce our gummies to a whole new community of cannabis lovers,' said Angela Brown, Co-Founder and CEO of COAST Cannabis Co. 'At COAST, we're all about creating high-quality, clean, and delicious edibles that people can feel good about. Partnering with The Cannabist Company allows us to expand our mission while staying true to our roots—delivering products made with care, integrity, and a little taste of the coast in every bite.' The infused gummies are now available at all gLeaf and Columbia Care locations in Maryland. In the coming months, COAST artisan chocolates will also be available. Find your local Maryland dispensary here: About The Cannabist Company (f/k/a Columbia Care) The Cannabist Company, formerly known as Columbia Care, is one of the most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 12 U.S. jurisdictions. The Company operates 81 facilities including 64 dispensaries and 17 cultivation and manufacturing facilities, including those under development. Columbia Care, now The Cannabist Company, is one of the original multi-state providers of cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the Company launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit Caution Concerning Forward-Looking Statements This press release contains certain statements that constitute 'forward-looking information' or 'forward-looking statements' within the meaning of applicable securities laws and reflect the Company's current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company's ability to execute on retail, wholesale, brand and product initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. In addition, security holders should review the risk factors discussed under 'Risk Factors' in Columbia Care's Form 10-K for the year ended December 31, 2023, as filed with Canadian and U.S. securities regulatory authorities and described from time to time in subsequent documents filed with applicable securities regulatory authorities.
Daily Mail
21-05-2025
- Health
- Daily Mail
Grandmother who lost five stone using Mounjaro claims the weight loss jabs left her looking like a 'melted welly' with 'saggy skin'
A grandmother who lost five stone using Mounjaro is now raising cash to fund tummy tuck surgery after claiming the jabs left her looking like a 'melted welly'. Angela Brown, from Cumbernauld in Lanarkshire, weighed 24 stone just a few years ago, but has since transformed her physique using a combination of exercise, healthy diet, and weight loss injectable, Mounjaro. Using diet and exercise only to begin with, the 52-year-old was able to ditch an impressive 6 stone, taking her to 18 stone, but she struggled to get any further with her weight loss, despite keeping up with natural techniques. Also struggling with Type 2 diabetes, cancer survivor Angela began taking Mounjaro on the advice of a health expert and watched in amazement as the 'weight just melted away', leaving her a total of 11 stone lighter. Starting her journey as a size 26, Angela has seen incredible results and has now slimmed down to a trim size 12 to 14 and is even in remission from diabetes. But following her weight loss, Angela revealed she has now been left with an enormity of 'excess skin', and is now campaigning on her own GoFundMe page to raise funds to have surgery abroad to remove it. Although she is pleased with her results, the grandmother said she still struggles with body confidence due to the excess skin left around her legs, arms and stomach. She said she can hardly look in the mirror and is 'embarrassed' by the 'saggy' skin left by the dramatic weight loss, she revealed during an interview with Glasgow Times. She told the paper: 'I've lost so much weight and my heath has vastly improved, but instead of feeling confident I hate looking in the mirror. 'My stomach stretches down to my knees and the amount of saggy skin on my legs has left me feeling like my body looks like a melted welly.' She added: 'I feel so embarrassed, and I have to go up a clothes size just to fit the skin hanging down into my trousers.' Much to her dismay, a cosmetic procedure to remove the skin is not be available on the NHS, meaning Angela would need to travel abroad to seek treatment. Unable to pay for her own surgery, she would need to spend £12,000 to have the three surgeries abroad for the results she wants. Writing on the charity website, Angela said she was 'looking for a little help towards surgeries', adding that she wasn't just looking for handouts, and was 'also saving towards this myself.' Since sharing the plea on the charity funding page last week, she has raised £5,000. Angela's incredible results were inspired by tragic circumstances, she told Glasgow Times. Using diet and exercise only to begin with, the 52-year-old was able to ditch an impressive 6st, taking her to 18st, but she struggled to get any further with her weight loss, despite keeping up with natural technique The grandmother said it was the death of her father, Robert, in 2023 that marked the turning point in her choosing to finally make a change. Not only that, but Angela has also faced 'cancer and other health issues', only some of which she put down to 'an unhealthy lifestyle'. Thanks to healthy changes and taking weight-loss drugs, Angela is also now in remission for Type 2 diabetes. Mounjaro, also known as GLP-1s, is the brand name for Tirzepatide - a drug that lowers blood sugar levels. It is one of a number of now popular weight-loss drugs such as Wegovy and Ozempic, that have become increasingly popular among people trying to shift pounds. It comes following the news that pharmacists are set to start dishing out weight-loss jabs on the NHS. Under government plans, just a short, over-the-counter consultation will be needed to get the likes of Ozempic and Mounjaro for the cost of an NHS prescription – this week frozen at £9.90. The Mail understands a deal worth tens of millions of pounds will be struck with a major pharmaceutical firm to fund a pilot scheme across the UK, with a view to eventually rolling it out to everyone in need. At the moment, the powerful injections are available to only a tiny number of people on the NHS – after talks with a specialist and in conjunction with other weight-loss methods. There is a two-year waiting list. But ministers plan to expand the drugs' use dramatically by dishing out prescriptions quickly and easily in 'creative' ways, such as through high street chemists, health centres and apps. It means, once the deal is signed, it will be possible to walk into a pharmacy and, after a short assessment, leave with a supply of jabs for £9.90.
The Irish Sun
19-05-2025
- Health
- The Irish Sun
I lost over 5st on Mounjaro but still avoid mirrors – I look like a melted welly with saggy skin down to my knees
A GRAN who shed more than five stone on Mounjaro is now fundraising to have surgery abroad - as she compares her saggy skin to a "melted welly". Angela Brown weighed 24st when she was diagnosed with Type 2 diabetes and knew she had to lose weight for her health. Advertisement 3 Angela Brown weighed 24st before embarking ona weight loss journey Credit: GOFUNDME 3 The gran is now a slim size 12/14 Credit: GOFUNDME 3 Angela used Mounjaro to help shed 5st when her weight loss 'stalled' Credit: Getty The 52-year-old managed to lose 6st naturally through a combination of dieting and exercise before her progress stalled. It was at this point she turned to the weight loss jabs to help her journey. Mounjaro is the brand name for Tirzepatide - a drug that lowers blood sugar levels. It produces more insulin and slows down how quickly food is digested. Advertisement Originally prescribed for people with type-2 diabetes, it is now available to those struggling with obesity with BMIs over 35. With the help of the jabs, Angela - from Cumbernauld, Lanarkshire - has now gone from a size 26 to a 12/14. She has more energy to run around after her grandkids and has reversed her diabetes. But despite her trimmer figure, she admits she hates looking in the mirror because she has been left with so much loose skin. Advertisement Most read in Fabulous She told the 'I've lost so much weight and my heath has vastly improved, but instead of feeling confident I hate looking in the mirror. I've lost 3 stone in 8 months on fat jabs - there's a common error new starters are making & it means nasty side effects "My stomach stretches down to my knees and the amount of saggy skin on my legs has left me feeling like my body looks like a melted welly. 'I feel so embarrassed, and I have to go up a clothes size just to fit the skin hanging down into my trousers. Advertisement "I was so heavy there was no possible way of losing weight without this happening and exercise won't help. "I've now hit my target weight and I'm off Mounjaro, I just want to get rid of the droopy skin and rebuild my confidence.' Unable to get the cosmetic provedure on the NHS, Angela says she is having to fork out £12,000 to have the three surgeries abroad. Advertisement She has managed to save £5,000 towards the ops by herself so she can "live life to the full without feeling embarrassed" by how she looks. Read more on the Irish Sun But she has also launched a GoFundMe appeal to help reach her overall goal. To donate to Angela's surgery fund, click Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines
The Sun
19-05-2025
- Health
- The Sun
I lost over 5st on Mounjaro but still avoid mirrors – I look like a melted welly with saggy skin down to my knees
A GRAN who shed more than five stone on Mounjaro is now fundraising to have surgery abroad - as she compares her saggy skin to a "melted welly". Angela Brown weighed 24st when she was diagnosed with Type 2 diabetes and knew she had to lose weight for her health. 3 3 3 The 52-year-old managed to lose 6st naturally through a combination of dieting and exercise before her progress stalled. It was at this point she turned to the weight loss jabs to help her journey. Mounjaro is the brand name for Tirzepatide - a drug that lowers blood sugar levels. It produces more insulin and slows down how quickly food is digested. Originally prescribed for people with type-2 diabetes, it is now available to those struggling with obesity with BMIs over 35. With the help of the jabs, Angela - from Cumbernauld, Lanarkshire - has now gone from a size 26 to a 12/14. She has more energy to run around after her grandkids and has reversed her diabetes. But despite her trimmer figure, she admits she hates looking in the mirror because she has been left with so much loose skin. She told the Glasgow Times: "The weight just melted away. It [Mounjaro] helped my metabolism to kick in and I lost five and a half stone. 'I've lost so much weight and my heath has vastly improved, but instead of feeling confident I hate looking in the mirror. I've lost 3 stone in 8 months on fat jabs - there's a common error new starters are making & it means nasty side effects "My stomach stretches down to my knees and the amount of saggy skin on my legs has left me feeling like my body looks like a melted welly. 'I feel so embarrassed, and I have to go up a clothes size just to fit the skin hanging down into my trousers. "I was so heavy there was no possible way of losing weight without this happening and exercise won't help. "I've now hit my target weight and I'm off Mounjaro, I just want to get rid of the droopy skin and rebuild my confidence.' Unable to get the cosmetic provedure on the NHS, Angela says she is having to fork out £12,000 to have the three surgeries abroad. She has managed to save £5,000 towards the ops by herself so she can "live life to the full without feeling embarrassed" by how she looks. But she has also launched a GoFundMe appeal to help reach her overall goal. To donate to Angela's surgery fund, click here. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines
